| 12/06/25 | GSK | 11:00:00 | 12 Jun 2025 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 25/05/22 | GSK | 15:41:00 | 25 May 2022 | | GSK | Director/PDMR Shareholding | GSK plc | PRN |
| 01/12/21 | GSK | 11:05:00 | 1 Dec 2021 | | GSK | Total Voting Rights | GSK plc | PRN |
| 17/04/14 | | 17:56:50 | 17 Apr 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 17/04/14 | | 17:56:21 | 17 Apr 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 17/04/14 | | 17:52:27 | 17 Apr 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 17/04/14 | | 17:50:33 | 17 Apr 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 17/04/14 | | 17:50:12 | 17 Apr 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 17/04/14 | | 17:24:42 | 17 Apr 2014 | | | GSK receives approval in Canada for Incruse | GlaxoSmithKline PLC | RNS |
| 15/04/14 | | 18:56:36 | 15 Apr 2014 | | | Tanzeum (albiglutide) receives FDA approval | GlaxoSmithKline PLC | RNS |
| 15/04/14 | | 16:39:44 | 15 Apr 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 15/04/14 | | 16:36:40 | 15 Apr 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 14/04/14 | | 17:34:16 | 14 Apr 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/04/14 | | 16:17:19 | 11 Apr 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/04/14 | | 16:15:18 | 11 Apr 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 11/04/14 | | 12:03:39 | 11 Apr 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/04/14 | | 16:14:17 | 10 Apr 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/04/14 | | 16:12:55 | 10 Apr 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 08/04/14 | | 17:11:21 | 8 Apr 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 08/04/14 | | 17:10:39 | 8 Apr 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 02/04/14 | | 11:52:25 | 2 Apr 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 02/04/14 | | 08:00:37 | 2 Apr 2014 | | | Update on Phase lll clinical trial of MAGE-A3 | GlaxoSmithKline PLC | RNS |
| 01/04/14 | | 13:52:52 | 1 Apr 2014 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 31/03/14 | | 08:00:08 | 31 Mar 2014 | | | GSK data from PIII STABILITY study of darapladib | GlaxoSmithKline PLC | RNS |
| 26/03/14 | | 13:07:33 | 26 Mar 2014 | | | Eperzan (albiglutide) receives EMA approval | GlaxoSmithKline PLC | RNS |
| 26/03/14 | | 10:17:46 | 26 Mar 2014 | | | Notice of AGM | GlaxoSmithKline PLC | RNS |
| 26/03/14 | | 10:07:45 | 26 Mar 2014 | | | Regulatory update on combined use of MEK/BRAF | GlaxoSmithKline PLC | RNS |
| 24/03/14 | | 09:56:40 | 24 Mar 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 21/03/14 | | 11:32:44 | 21 Mar 2014 | | | GSK - historical restated financial information | GlaxoSmithKline PLC | RNS |
| 20/03/14 | | 07:00:10 | 20 Mar 2014 | | | MAGE-A3 MAGRIT Phase III trial results | GlaxoSmithKline PLC | RNS |
| 17/03/14 | | 15:59:54 | 17 Mar 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 17/03/14 | | 15:56:31 | 17 Mar 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 13/03/14 | | 16:00:22 | 13 Mar 2014 | | | Additional Listing | GlaxoSmithKline PLC | RNS |
| 12/03/14 | | 17:08:11 | 12 Mar 2014 | | | Mepolizumab Positive Phase III Asthma Study Result | GlaxoSmithKline PLC | RNS |
| 12/03/14 | | 16:34:44 | 12 Mar 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 12/03/14 | | 16:23:34 | 12 Mar 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 10/03/14 | | 07:00:05 | 10 Mar 2014 | | | GSK increases stake in its Indian pharma. co. | GlaxoSmithKline PLC | RNS |
| 06/03/14 | | 10:57:51 | 6 Mar 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 05/03/14 | | 15:14:54 | 5 Mar 2014 | | | Dividend Declaration | GlaxoSmithKline PLC | RNS |
| 03/03/14 | | 16:14:48 | 3 Mar 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 03/03/14 | | 12:39:31 | 3 Mar 2014 | | | Total Voting Rights | GlaxoSmithKline PLC | RNS |
| 03/03/14 | | 12:28:58 | 3 Mar 2014 | | | GSK files its Annual Report 2013 on form 20F | GlaxoSmithKline PLC | RNS |
| 27/02/14 | | 17:23:04 | 27 Feb 2014 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 27/02/14 | | 15:11:59 | 27 Feb 2014 | | | Annual Financial Report | GlaxoSmithKline PLC | RNS |
| 26/02/14 | | 17:24:07 | 26 Feb 2014 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 26/02/14 | | 16:54:41 | 26 Feb 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 26/02/14 | | 16:53:04 | 26 Feb 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 26/02/14 | | 12:22:01 | 26 Feb 2014 | | | Director/PDMR Shareholding | GlaxoSmithKline PLC | RNS |
| 25/02/14 | | 17:16:04 | 25 Feb 2014 | | | Transaction in Own Shares | GlaxoSmithKline PLC | RNS |
| 25/02/14 | | 14:59:53 | 25 Feb 2014 | | | Director Declaration | GlaxoSmithKline PLC | RNS |